Fetomaternal Expression of Glucose Transporters (GLUTs)-Biochemical, Cellular and Clinical Aspects

Nutrients. 2022 May 12;14(10):2025. doi: 10.3390/nu14102025.

Abstract

Several types of specialized glucose transporters (GLUTs) provide constant glucose transport from the maternal circulation to the developing fetus through the placental barrier from the early stages of pregnancy. GLUT1 is a prominent protein isoform that regulates placental glucose transfer via glucose-facilitated diffusion. The GLUT1 membrane protein density and permeability of the syncytial basal membrane (BM) are the main factors limiting the rate of glucose diffusion in the fetomaternal compartment in physiological conditions. Besides GLUT1, the GLUT3 and GLUT4 isoforms are widely expressed across the human placenta. Numerous medical conditions and molecules, such as hormones, adipokines, and xenobiotics, alter the GLUT's mRNA and protein expression. Diabetes upregulates the BM GLUT's density and promotes fetomaternal glucose transport, leading to excessive fetal growth. However, most studies have found no between-group differences in GLUTs' placental expression in macrosomic and normal control pregnancies. The fetomaternal GLUTs expression may also be influenced by several other conditions, such as chronic hypoxia, preeclampsia, and intrahepatic cholestasis of pregnancy.

Keywords: diabetes; glucose transporter proteins; hyperglycemia in pregnancy; placenta; pregnancy.

Publication types

  • Review

MeSH terms

  • Biological Transport
  • Female
  • Glucose / metabolism
  • Glucose Transport Proteins, Facilitative* / genetics
  • Glucose Transport Proteins, Facilitative* / metabolism
  • Humans
  • Placenta* / metabolism
  • Pregnancy
  • Protein Isoforms

Substances

  • Glucose Transport Proteins, Facilitative
  • Protein Isoforms
  • Glucose

Grants and funding

This research received no external funding.